The study found that Focal One's treatment methods match up with the gold star standard of surgery, and improve quality of life outcomes.

Avelumab is under clinical development by Merck and currently in Phase II for Ovarian Cancer. According to GlobalData, Phase II drugs for Ovarian Cancer have a 26% phase transition success rate (PTSR) ...

Discover the truth about prostate health with our in-depth ProstaVive reviews, exploring benefits, ingredients, and real user ...

Urinary retention—the complete inability to urinate—can occur after surgery and may be chronic or acute. Symptoms include discomfort in the bladder area, lower abdominal pain, trouble starting to pee, ...

The FDA has approved cosibelimab (marketed under the brand name Unloxcyt), a new drug for adults with advanced cutaneous squamous cell carcinoma (CSCC), a type of skin cancer.

Urinary tract infections (UTIs ... of vitamin C to your immune system. The spray bottle format means you can adjust the dosage to your needs. Increasing vitamin C intake may decrease your risk ...

Some men receiving radiation therapy for prostate cancer can have their treatment compressed into just 5 sessions, compared with the minimum of 20 that is often used, according to results from a large ...

and digestive system cancers: Jaffer A. Ajani, MD, Professor of Medicine, MD Anderson Cancer Center Susana Banerjee, MBBS MA PhD FRCP, Professor and Medical Oncologist, The Royal Marsden NHS ...

Symptoms of Peritoneal Cancer People with peritoneal cancer often have few symptoms until the disease is fairly advanced. When symptoms occur, they are often vague and nonspecific and include fatigue, ...

making them more prone to cancer-causing errors like mutations. Chronic inflammation also suppresses the immune system's ability to destroy those abnormal cells. Dr Timothy Yeatman ...

Colon cancers may be surging in under 50s because of a rise in 'accelerated agers', according to a new study. These people have a biological age that is higher than their chronological age ...